日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Glycan-dependent HIV-specific neutralizing antibodies bind to cells of uninfected individuals

依赖于糖基化的HIV特异性中和抗体能够与未感染者的细胞结合。

Blazkova, Jana; Refsland, Eric W; Clarridge, Katherine E; Shi, Victoria; Justement, J Shawn; Huiting, Erin D; Gittens, Kathleen R; Chen, Xuejun; Schmidt, Stephen D; Liu, Cuiping; Doria-Rose, Nicole; Mascola, John R; Heredia, Alonso; Moir, Susan; Chun, Tae-Wook

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals

分析治疗中断和重新开始抗逆转录病毒疗法对感染者体内HIV病毒库和免疫学参数的影响

Clarridge, Katherine E; Blazkova, Jana; Einkauf, Kevin; Petrone, Mary; Refsland, Eric W; Justement, J Shawn; Shi, Victoria; Huiting, Erin D; Seamon, Catherine A; Lee, Guinevere Q; Yu, Xu G; Moir, Susan; Sneller, Michael C; Lichterfeld, Mathias; Chun, Tae-Wook

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection

一项针对早期开始抗逆转录病毒治疗的 HIV 感染者开展的治疗性疫苗接种的随机对照安全性/有效性试验

Sneller, Michael C; Justement, J Shawn; Gittens, Kathleen R; Petrone, Mary E; Clarridge, Katherine E; Proschan, Michael A; Kwan, Richard; Shi, Victoria; Blazkova, Jana; Refsland, Eric W; Morris, Daryl E; Cohen, Kristen W; McElrath, M Juliana; Xu, Rong; Egan, Michael A; Eldridge, John H; Benko, Erika; Kovacs, Colin; Moir, Susan; Chun, Tae-Wook; Fauci, Anthony S

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

HIV抗体VRC01对治疗中断后病毒反弹的影响

Bar, Katharine J; Sneller, Michael C; Harrison, Linda J; Justement, J Shawn; Overton, Edgar T; Petrone, Mary E; Salantes, D Brenda; Seamon, Catherine A; Scheinfeld, Benjamin; Kwan, Richard W; Learn, Gerald H; Proschan, Michael A; Kreider, Edward F; Blazkova, Jana; Bardsley, Mark; Refsland, Eric W; Messer, Michael; Clarridge, Katherine E; Tustin, Nancy B; Madden, Patrick J; Oden, KaSaundra; O'Dell, Sijy J; Jarocki, Bernadette; Shiakolas, Andrea R; Tressler, Randall L; Doria-Rose, Nicole A; Bailer, Robert T; Ledgerwood, Julie E; Capparelli, Edmund V; Lynch, Rebecca M; Graham, Barney S; Moir, Susan; Koup, Richard A; Mascola, John R; Hoxie, James A; Fauci, Anthony S; Tebas, Pablo; Chun, Tae-Wook

Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican Descent

一名墨西哥裔儿童因RFXANK基因新突变导致主要组织相容性复合体II类缺陷

Clarridge, Katherine; Leitenberg, David; Loechelt, Brett; Picard, Capuchine; Keller, Michael

Perspectives of Decisional Surrogates and Patients Regarding Critical Illness Genetic Research

决策代理人和患者对重大疾病遗传研究的看法

Freeman, Bradley D; Bolcic-Jankovic, Dragana; Kennedy, Carie R; LeBlanc, Jessica; Eastman, Alexander; Barillas, Jennifer; Wittgen, Catherine M; Indsey, Kathryn; Mahmood, Rumel S; Clarridge, Brian R

Clinical Significance and Characterization of Streptococcus tigurinus Isolates in an Adult Population

成年人群中虎纹链球菌分离株的临床意义和特征

Lori Bourassa, J E Clarridge 3rd

In Vitro Activity of Retapamulin and Antimicrobial Susceptibility Patterns in a Longitudinal Collection of Methicillin-Resistant Staphylococcus aureus Isolates from a Veterans Affairs Medical Center

雷他帕林体外活性及对退伍军人事务医疗中心纵向收集的耐甲氧西林金黄色葡萄球菌分离株的抗菌药物敏感性模式

Harrington, Amanda T; Black, Jennifer A; Clarridge, Jill E 3rd

Does difficulty functioning in the surrogate role equate to vulnerability in critical illness research? Use of path analysis to examine the relationship between difficulty providing substituted judgment and receptivity to critical illness research participation

在替代角色中表现困难是否等同于在重症疾病研究中的脆弱性?运用路径分析法探讨提供替代判断的困难程度与参与重症疾病研究的意愿之间的关系

Clarridge, Brian R; Bolcic-Jankovic, Dragana; LeBlanc, Jessica; Mahmood, Rumel S; Kennedy, Carie R; Freeman, Bradley D

Molecular analysis and clinical significance of Lactobacillus spp. recovered from clinical specimens presumptively associated with disease

从疑似与疾病相关的临床标本中分离出的乳杆菌属的分子分析及其临床意义

Martinez, Raquel M; Hulten, Kristina G; Bui, Uyen; Clarridge, Jill E 3rd